Home > Financial Ratios > ALBERT DAVID

ALBERT DAVID
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

ALBERT DAVID Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -68.6874.625.4555.72-3.07

What is the latest Core EBITDA Growth ratio of ALBERT DAVID ?

The latest Core EBITDA Growth ratio of ALBERT DAVID is -68.68 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-68.68
Mar202474.62
Mar20235.45
Mar202255.72
Mar2021-3.07

How is Core EBITDA Growth of ALBERT DAVID Trending?

Years Core EBITDA Growth % Change
Mar2025 -68.68
Negative
Mar2024 74.62
1,269.17
Mar2023 5.45
-90.22
Mar2022 55.72
Positive
Mar2021 -3.07 -

Other Financial Ratios of ALBERT DAVID


Compare Core EBITDA Growth ratio of peers of ALBERT DAVID

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALBERT DAVID ₹403.4 Cr 2.7% -3.1% -38.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,442.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹171,878.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,301.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹109,030.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,023.0 Cr 1.3% 3.8% 4.5% Stock Analytics


ALBERT DAVID Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALBERT DAVID

2.7%

-3.1%

-38.9%

SENSEX

0.5%

0.8%

7.2%


You may also like the below Video Courses